Skip to content

Prospective multi-center observational cohort study on the efficacy and prognostic analysis of functional precision medicine for guiding treatment in relapsed or refractory pediatric leukemia

Prospective multi-center observational cohort study on the efficacy and prognostic analysis of functional precision medicine for guiding treatment in relapsed or refractory pediatric leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098273
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myeloid leukemia, acute lymphoblastic leukemia, juvenile myelomonocytic leukemia, mixed phenotype acute leukemia

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.Patients are <= 18 years old and meeting WHO diagnostic criteria for relapsed / refractory leukemia;

Exclusion criteria

Exclusion criteria: 1.Children who did not agree to be included in this study;

Design outcomes

Primary

MeasureTime frame
Minor residual diseases;event free survival rate;

Secondary

MeasureTime frame
recurrence rate;overall survival rate;incidence of treatment-related adverse reactions;

Countries

China

Contacts

Public ContactYan-Lai Tang

The First Affiliated Hospital,Sun Yat-sen University

tangylai@mail.sysu.edu.cn+86 156 2620 2579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026